Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023
We anticipate reaching important milestones in the upcoming quarters,” said Anthony Fernando, Asensus Surgical President and CEO.
- We anticipate reaching important milestones in the upcoming quarters,” said Anthony Fernando, Asensus Surgical President and CEO.
- The LUNA System's development is in progress and is now entering the testing and evaluation phase before regulatory submissions.
- Future milestones include freezing the system's design in early 2024, followed by verification and validation testing, and pilot manufacturing.
- Revenue in the third quarter of 2023 included $0.5 million in lease revenue, $0.3 million in instruments and accessories, and $0.3 million in services.